Non-hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Non-hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-02Clinical Trial Update: Tazemetostat and Venetoclax in Relapsed/Refractory Non-Hodgkin Lymphoma [Phase 1]
Phase 1 clinical trial of tazemetostat plus venetoclax for relapsed/refractory non-Hodgkin lymphoma has been terminated, including diffuse l…
-
CLINICAL_TRIALS trial_result · 2026-04-01Clinical Trial Update: Study of VAY736 as Single Agent and in Combination With Select Antineoplastic Agents in Patients With Non-Hodgkin Lymphoma [Phase 1]
Phase 1 study update for VAY736 in non-Hodgkin lymphoma shows the trial status as terminated, evaluating VAY736 alone and in combination wit…
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: Cholecalciferol in Newly Diagnosed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia With Vitamin D Deficiency [NA]
A completed clinical trial evaluated cholecalciferol (vitamin D3) in patients with chronic lymphocytic leukemia or non-Hodgkin lymphoma who …
-
CLINICAL_TRIALS trial_result · 2026-03-25Clinical Trial Update: Study to Assess the Safety and Tolerability of CFT7455 in Relapsed/Refractory Non-Hodgkin's Lymphoma or Multiple Myeloma [Phase 1]
Phase 1 safety and tolerability study of CFT7455 in relapsed/refractory non-Hodgkin's lymphoma and multiple myeloma is currently active but …
-
CLINICAL_TRIALS trial_result · 2026-03-20Clinical Trial Update: A Study of LY4152199 in Participants With Previously Treated B-cell Cancers (BAF_FRontier-1 ) [Phase 1]
A Phase 1 study of LY4152199 in previously treated B-cell cancers is listed, with the trial currently NOT_YET_RECRUITING.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-03-16Clinical Trial Update: A Study Evaluating the Safety and Efficacy of GLPG5101 (19CP02) in Participants With Non-Hodgkin Lymphoma [Phase 1, Phase 2]
A Phase 1/2 clinical trial update on the investigational drug GLPG5101 (19CP02) for Relapsed/Refractory B-cell Non-Hodgkin Lymphoma, with th…
-
CLINICAL_TRIALS trial_result · 2026-03-12Clinical Trial Update: Phase 1, Open-label, Dose-escalation Trial With CD38-SADA:177 Lu-DOTA Drug Complex in Subjects With Relapsed or Refractory Non-Hodgkin Lymphoma [Phase 1]
A Phase 1, open-label dose-escalation trial of the CD38-targeted radiopharmaceutical CD38-SADA:177Lu-DOTA Drug Complex in relapsed or refrac…
-
CLINICAL_TRIALS trial_result · 2026-03-11Clinical Trial Update: Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas [Phase 1, Phase 2]
Phase 1/2 study evaluating the combination of lenalidomide with DA-EPOCH-R in MYC-associated B-cell lymphomas has completed, and results hav…
-
CLINICAL_TRIALS trial_result · 2026-03-11Clinical Trial Update: A Study to Evaluate the Safety and Preliminary Efficacy of ATA3219 in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma [Phase 1]
A Phase 1 trial update for ATA3219 in relapsed/refractory B-cell non-Hodgkin lymphoma notes that the study has been terminated, with safety …
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders [NA]
This update reports the completed status of a trial assessing bone marrow and kidney transplant for patients with chronic kidney disease and…
-
CLINICAL_TRIALS trial_result · 2026-03-05Clinical Trial Update: A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab Monotherapy in Participants With Select B-Cell Malignancies [Phase 2]
This Phase 2 trial evaluates mosunetuzumab monotherapy for select B-cell malignancies, including Non-Hodgkin lymphoma, with the study curren…
-
CLINICAL_TRIALS trial_result · 2026-03-04Clinical Trial Update: TCRαβ-depleted Progenitor Cell Graft With Additional Memory T-cell DLI, Plus Selected Use of Blinatumomab, in Naive T-cell Depleted Haploidentical Donor Hematopoietc Cell Transplantation for Hematologic Malignancies [Phase 2]
Phase 2 clinical trial update evaluating TCRαβ-depleted progenitor cell graft with added memory T-cell donor lymphocyte infusion and selecti…
-
CLINICAL_TRIALS trial_result · 2026-03-04Clinical Trial Update: Trial of PRO1160 (GEN1160) in Relapsed or Refractory Non-Hodgkin Lymphoma (NHL) (PRO1160-001) [Phase 1, Phase 2]
Genmab's PRO1160 (GEN1160) Phase 1/2 trial in relapsed or refractory non-Hodgkin lymphoma has been terminated; the study also included renal…
-
CLINICAL_TRIALS trial_result · 2026-03-03Clinical Trial Update: Response-Adapted Therapy With Copanlisib and Rituximab in Untreated Follicular Lymphoma [Phase 2]
A Phase 2 trial of response-adapted therapy with copanlisib plus rituximab in previously untreated follicular lymphoma; results were posted …
-
CLINICAL_TRIALS trial_result · 2026-03-02Clinical Trial Update: A Study to Evaluate the Safety, Pharmacokinetics and Preliminary Anti-Tumor Activity of Englumafusp Alfa in Combination With Obinutuzumab and in Combination With Glofitamab Following a Pre-Treatment Dose of Obinutuzumab in Participants With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma [Phase 1, Phase 2]
Roche is conducting a Phase 1/2 trial to evaluate Englumafusp Alfa in combination with Obinutuzumab and in combination with Glofitamab after…
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: Impact of Respiratory Training in Lymphoma Survivors [NA]
A terminated clinical trial evaluating respiratory training in lymphoma survivors has posted results as of 2026-02-27. The study was sponsor…
-
CLINICAL_TRIALS trial_result · 2026-02-25Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of Relatlimab Plus Nivolumab in Pediatric and Young Adults With Hodgkin and Non-Hodgkin Lymphoma [Phase 1, Phase 2]
A completed Phase 1/2 trial evaluating the safety, tolerability, drug levels, and preliminary efficacy of relatlimab plus nivolumab in pedia…
-
CLINICAL_TRIALS trial_result · 2026-02-18Clinical Trial Update: An Open-label, Dose Escalation Trial to Evaluate the Safety and Pharmacokinetics of HMPL-523 in Patients With Lymphoma [Phase 1]
This is an open-label, dose-escalation Phase 1 trial of HMPL-523 in patients with Non-Hodgkin lymphoma. The study has been terminated and re…
-
CLINICAL_TRIALS trial_result · 2026-02-11Clinical Trial Update: CD19 CAR T Cells in Patients With Relapsed or Refractory CD19 Positive B-cell Lymphoma [Phase 1]
Phase 1 trial update reporting completion of a study evaluating CD19-targeted CAR T cells in relapsed or refractory CD19-positive B-cell lym…
-
CLINICAL_TRIALS trial_result · 2026-02-09Clinical Trial Update: A Study to Evaluate the Tolerability, Safety, and Efficacy of an Anti-CD19 CAR-T Product in Patients With B-cell Lymphoproliferative Disorders [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating a CD19-targeted CAR-T therapy for B-cell lymphoproliferative disorders has completed, assessing tolera…
-
CLINICAL_TRIALS trial_result · 2026-02-06Clinical Trial Update: EBV CTLs Expressing CD30 Chimeric Receptors For CD 30+ Lymphoma [Phase 1]
A Phase 1 trial evaluating EBV-specific cytotoxic T lymphocytes engineered to express a CD30 chimeric receptor for CD30-positive Hodgkin lym…
-
CLINICAL_TRIALS trial_result · 2026-02-05Clinical Trial Update: Study to Evaluate the Safety and Efficacy of a Combination of Favezelimab (MK-4280) and Pembrolizumab (MK-3475) in Participants With Hematologic Malignancies (MK-4280-003) [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating the safety and efficacy of combining favezelimab (MK-4280) with pembrolizumab (MK-3475) in patients wi…
-
CLINICAL_TRIALS trial_result · 2026-02-02Clinical Trial Update: Observational Study of People Living With HIV Treated With CD19-directed CAR T Cell
An observational study of people living with HIV treated with CD19-directed CAR T-cell therapy has completed.
-
CLINICAL_TRIALS trial_result · 2026-02-02Clinical Trial Update: Tandem Stem Cell Transplantation for Non-Hodgkin's Lymphoma [Phase 2]
A Phase 2 clinical trial evaluating tandem stem cell transplantation for Non-Hodgkin lymphoma is currently active but not recruiting, sponso…
-
CLINICAL_TRIALS trial_result · 2026-01-30Clinical Trial Update: T-cells or EBV Specific CTLs, Advanced B-Cell NHL and CLL [Phase 1]
Phase 1 trial evaluating EBV-specific cytotoxic T lymphocytes for advanced B-cell non-Hodgkin lymphoma and chronic lymphocytic leukemia has …